<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.34215/1609-1175-2024-1-39-42</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-2687</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Нарушение антиоксидантной функции у детей с диабетическим кетоацидозом</article-title><trans-title-group xml:lang="en"><trans-title>Decreased antioxidant capacity in children with diabetic ketoacidosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4705-3823</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Быков</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bykov</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Быков Юрий Витальевич – канд. мед. наук, ассистент кафедры анестезиологии и реаниматологии с курсом ПДО </p><p>355017, г. Ставрополь, ул. Мира, 310   тел.: + 7 (962) 443-04-92 </p></bio><bio xml:lang="en"><p>Yuri V. Bykov, Cand. Sci. (Med.), assist. of Dept. of anesthesiology and intensive care with postgraduate course </p><p>310 Mira str., Stavropol, 355017  phone: + 7 (962) 443-04-92  </p></bio><email xlink:type="simple">yubykov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батурин</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Baturin</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ставрополь</p></bio><bio xml:lang="en"><p>Stavropol</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьева</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobyova</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ставрополь</p></bio><bio xml:lang="en"><p>Stavropol</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вартанян</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vartanyan</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ставрополь</p></bio><bio xml:lang="en"><p>Stavropol</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ставропольский государственный медицинский университет ; Городская детская клиническая больница им. Г.К. Филиппского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Stavropol State Medical University ; City Children’s Clinical Hospital named G.K. Filippsky</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Ставропольский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Stavropol State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Городская детская клиническая больница им. Г.К. Филиппского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>City Children’s Clinical Hospital named G.K. Filippsky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>18</day><month>05</month><year>2024</year></pub-date><volume>0</volume><issue>1</issue><fpage>39</fpage><lpage>42</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Быков Ю.В., Батурин В.А., Воробьева А.П., Вартанян А.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Быков Ю.В., Батурин В.А., Воробьева А.П., Вартанян А.А.</copyright-holder><copyright-holder xml:lang="en">Bykov Y.V., Baturin V.A., Vorobyova A.P., Vartanyan A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/2687">https://www.tmj-vgmu.ru/jour/article/view/2687</self-uri><abstract><p>Цель: проанализировать уровни антиоксидантных ферментов – супероксиддисмутазы (СОД) и глутатионпероксидазы (ГП) на фоне диабетического кетоацидоза (ДКА) при сахарном диабете (СД) 1-го типа у детей и подростков. Материалы и методы. Обследовано 74 ребенка: 50 детей с ДКА (группа исследования) и 24 условно здоровых ребенка (контрольная группа). Дети из группы исследования были поделены на две подгруппы: 1-я подгруппа – дети с ДКА на фоне дебюта СД 1-го типа (n = 27), 2 подгруппа – дети с ДКА на фоне хронического СД 1-го типа (n = 23). У всех детей выполнено определение концентрации СОД и ГП в плазме крови методом иммуноферментного анализа. Достоверность между данными определяли при помощи критериев Манна – Уитни, Краскела – Уоллиса и коэффициента Спирмена. Результаты. Выявлено достоверное уменьшение СОД и ГП у детей с ДКА: 13130 [13005–18255] Pg/ml и 50,085 [42,02–70,325] Ng/ml, по сравнению с контролем: 16415 [13370–19935] Pg/ml и 84,695 [52,49–144,5] Ng/ml соответственно. Отмечены минимальные показатели СОД и ГП у пациентов с ДКА на фоне хронического течения СД 1-го типа по сравнению с детьмипри дебюте заболевания. Показана достоверная корреляция между возрастом, длительностью заболевания, количеством ДКА в анамнезе и низкими значениями СОД и ГП. Заключение. Обнаружено снижение антиоксидантной функции у детей с ДКА при СД 1-го типа. СОД и ГП могут служить маркерами оксидативного стресса при ДКА в педиатрической практике. Максимально раннее определение СОД и ГП может улучшить и терапию ДКА у детей и подростков.</p></abstract><trans-abstract xml:lang="en"><p>Objective. To analyze the levels of antioxidant enzyme superoxide dismutase (SOD) and glutathione peroxidase (GP) against the background of diabetic ketoacidosis (DKA) in type 1 diabetes mellitus (DM) children and adolescents. Materials and methods. The study involved examination of 74 children: 50 DKA children (study group) and 24 relatively healthy children (control group). The study group children were divided into two subgroups: subgroup 1 included children with DKA against the background of type 1 DM onset (n=27), subgroup 2 consisted of children with DKA against the background of chronic type 1 DM (n=23). SOD and GP concentrations in blood plasma were determined in all children by enzyme immunoassay. The reliability between the data was estimated using the Mann-Whitney test, Kruskal-Wallis test and Spearman coefficient. Results. A significant decrease in SOD and GP in children with DKA was revealed as follows: 13130 [13005–18255] Pg/ml and 50.085 [42.02–70.325] Ng/ml, compared to controls: 16415 [13370–19935] Pg/ml and 84.695 [52.49–144.5] Ng/ml, respectively. Minimal SOD and GP were noted in patients with DKA at the background of chronic type 1 DM, compared to DM onset children. The study indicates a reliable correlation between age, duration of the disease, number of DKA in the history and low values of SOD and GP. Conclusion. Decreased antioxidant capacity was found in children with DKA in type 1 DM. SOD and GP can be considered in pediatric practice as markers of oxidative stress in DKA. In addition, an early detection of SOD and GP contributes to the efficient therapy of DKA in children and adolescents.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет 1-го типа</kwd><kwd>диабетический кетоацидоз</kwd><kwd>антиоксидантная функция</kwd><kwd>супероксиддисмутаза</kwd><kwd>глутатионпероксидаза</kwd></kwd-group><kwd-group xml:lang="en"><kwd>type 1 diabetes mellitus</kwd><kwd>diabetic ketoacidosis</kwd><kwd>antioxidant capacity</kwd><kwd>superoxide dismutase</kwd><kwd>glutathione peroxidase</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Janner M., Saner C. Impact of Type 1 Diabetes Mellitus on Bone Health in Children. Horm Res Paediatr. 2022;95(3):205–14. doi: 10.1159/000521627</mixed-citation><mixed-citation xml:lang="en">Janner M., Saner C. Impact of Type 1 Diabetes Mellitus on Bone Health in Children. Horm Res Paediatr. 2022;95(3):205–14. doi: 10.1159/000521627</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Малюжинская Н.В., Шишиморов И.Н., Магницкая О.В., Степаненко К.В., Полякова О.В., Клиточенко Г.В., Петрова И.В., Емельянова С.А., Скиба А.П. Возможности фармакотерапии на преклинической стадии кардиоваскулярной автономной нейропатии у детей с сахарным диабетом 1-го типа.Фармация и фармакология. 2022;10(1):93–103. doi: 10.19163/2307-9266-2022-10-1-93-103</mixed-citation><mixed-citation xml:lang="en">Malyuzhinskaya NV, Shishimorov IN, Magnitskaya OV, Stepanenko KV, Polyakova OV, Klitochenko GV, Petrova IV, Emelyanova SA, Skiba AP. Pharmacotherapy possibilities of cardiovascular autonomic neuropathy in children with type 1 diabetes mellitus at the preclinical stage. Pharmacy and Pharmacology. 2022;10(1):93–103 (In Russ.). doi: 10.19163/2307-9266-2022-10-1-93-103</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Быков Ю.В. Диабетический кетоацидоз у детей и подростков: от патофизиологии до профилактики. Забайкальский медицинский вестник. 2021;2:85–95. doi: 10.52485/19986173_2021_2_85</mixed-citation><mixed-citation xml:lang="en">Bykov YuV. Diabetic ketoacidosis in children and adolescents: From pathophysiology to prevention. The Transbaikalian Medical Bulletin. 2021;2:85–95 (In Russ.) doi: 10.52485/19986173_2021_2_85</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Otal Y, Kahraman FA, Haydar FG, Erel Ö. Dynamic thiol/ disulfide homeostasis as oxidative stress marker in diabetic ketoacidosis. Eur J Clin Invest. 2018;48(10):e13006. doi: 10.1111/eci.13006</mixed-citation><mixed-citation xml:lang="en">Otal Y, Kahraman FA, Haydar FG, Erel Ö. Dynamic thiol/ disulfide homeostasis as oxidative stress marker in diabetic ketoacidosis. Eur J Clin Invest. 2018;48(10):e13006. doi: 10.1111/eci.13006</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kostopoulou E, Livada I, Partsalaki I, Lamari F, Skiadopoulos S, Rojas Gil AP, Spiliotis BE. The role of carbohydrate counting in glycemic control and oxidative stress in patients with type 1 diabetes mellitus (T1DM). Hormones (Athens). 2020;19(3):433–8. doi: 10.1007/s42000-020-00189-8</mixed-citation><mixed-citation xml:lang="en">Kostopoulou E, Livada I, Partsalaki I, Lamari F, Skiadopoulos S, Rojas Gil AP, Spiliotis BE. The role of carbohydrate counting in glycemic control and oxidative stress in patients with type 1 diabetes mellitus (T1DM). Hormones (Athens). 2020;19(3):433–8. doi: 10.1007/s42000-020-00189-8</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hoffman WH, Siedlak SL, Wang Y, Castellani RJ, Smith MA. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res.2011;1369:194–202. doi: 10.1016/j.brainres.2010.10.085</mixed-citation><mixed-citation xml:lang="en">Hoffman WH, Siedlak SL, Wang Y, Castellani RJ, Smith MA. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res.2011;1369:194–202. doi: 10.1016/j.brainres.2010.10.085</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress. A concise review. Saudi Pharm J.2016; 24(5): 547–53. doi: 10.1016/j.jsps.2015.03.013</mixed-citation><mixed-citation xml:lang="en">Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress. A concise review. Saudi Pharm J.2016; 24(5): 547–53. doi: 10.1016/j.jsps.2015.03.013</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Suys B, de Beeck LO, Rooman R, Kransfeld S, Heuten S, Goovaerts I, Vrints C, de Wolf D, Matthys D, Manuel-y-Keenoy B. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase? Pediatr Res. 2007;62(4):456–61. doi: 10.1203/PDR.0b013e318142581a</mixed-citation><mixed-citation xml:lang="en">Suys B, de Beeck LO, Rooman R, Kransfeld S, Heuten S, Goovaerts I, Vrints C, de Wolf D, Matthys D, Manuel-y-Keenoy B. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase? Pediatr Res. 2007;62(4):456–61. doi: 10.1203/PDR.0b013e318142581a</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. DiagnPathol.2007;2:22. doi: 10.1186/1746-1596-2-22</mixed-citation><mixed-citation xml:lang="en">Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. DiagnPathol.2007;2:22. doi: 10.1186/1746-1596-2-22</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kueakhai P, Chaithirayanon K, Chaiwichien A, Samrit T, Osotprasit S, Suksomboon P, Jaikua W, Sobhon P, Changklungmoa N. Monoclonal antibody against Fasciola gigantica glutathione peroxidase and their immunodiagnosis potential for fasciolosis. Vet Parasitol. 2019;276:108979. doi: 10.1016/j.vetpar.2019.108979</mixed-citation><mixed-citation xml:lang="en">Kueakhai P, Chaithirayanon K, Chaiwichien A, Samrit T, Osotprasit S, Suksomboon P, Jaikua W, Sobhon P, Changklungmoa N. Monoclonal antibody against Fasciola gigantica glutathione peroxidase and their immunodiagnosis potential for fasciolosis. Vet Parasitol. 2019;276:108979. doi: 10.1016/j.vetpar.2019.108979</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">El Amrousy D., El-Afify D., Shabana A. Relationship between bone turnover markers and oxidative stress in children with type 1 diabetes mellitus. Pediatr Res. 2021;89(4):878–81. doi: 10.1038/s41390-020-01197-5</mixed-citation><mixed-citation xml:lang="en">El Amrousy D., El-Afify D., Shabana A. Relationship between bone turnover markers and oxidative stress in children with type 1 diabetes mellitus. Pediatr Res. 2021;89(4):878–81. doi: 10.1038/s41390-020-01197-5</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chaudhuri A., Umpierrez G.E. Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia. J Diabetes Complications. 2012; 26(4): 257–8. doi: 10.1016/j.jdiacomp.2012.04.016</mixed-citation><mixed-citation xml:lang="en">Chaudhuri A., Umpierrez G.E. Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia. J Diabetes Complications. 2012; 26(4): 257–8. doi: 10.1016/j.jdiacomp.2012.04.016</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Karavanaki K, Karanika E, Georga S, Bartzeliotou A, Tsouvalas M, Konstantopoulos I. Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocrine Journal.2011;58:1045–53. doi: 10.1507/endocrj.ej11-0024</mixed-citation><mixed-citation xml:lang="en">Karavanaki K, Karanika E, Georga S, Bartzeliotou A, Tsouvalas M, Konstantopoulos I. Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocrine Journal.2011;58:1045–53. doi: 10.1507/endocrj.ej11-0024</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
